Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.60), $0.12 better than the analyst estimate of ($1.72). Revenue for the quarter came in at $35.4 million versus the consensus estimate of $33.72 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.